Characterisation and applications of bacteriocinogenic Isolates from the deep-sea fish microbiome
| dc.contributor.advisor | Ross, R. Paul | |
| dc.contributor.advisor | Hill, Colin | |
| dc.contributor.advisor | Stanton, Catherine | |
| dc.contributor.author | Uniacke-Lowe, Shona | en |
| dc.date.accessioned | 2024-09-18T14:03:13Z | |
| dc.date.available | 2024-09-18T14:03:13Z | |
| dc.date.issued | 2024 | en |
| dc.date.submitted | 2024 | |
| dc.description.abstract | One of the major grand challenges confronting humanity in the coming decades is the increased risk of infection, stemming from the alarming surge in antimicrobial resistance among pathogenic bacteria. Consequently, there is an urgent need to uncover new antimicrobials and mechanisms, including antimicrobial bacterial strains, which could potentially substitute for some of the widely employed antibiotics. In this respect, the main goal of this thesis work was initially to explore deep-sea fish microbiomes as a source of antimicrobials and their prospective clinical applications. Our hypothesis was that these microbiomes represent some of the last bastions of microbial communities that have been negligibly impacted by human activity and as such are untapped for this purpose. Although still very limited, there is an accumulating number of studies where marine fish microbiomes are being characterised and assessed for their bacteriocinogenic potential (Chapter 1). In many cases these microbiomes are dominated by Gram-negative Pseudomonadota and Gram-positive Bacillota and Actinomycetota. They can be important hosts to uncommon species that are not found in the surrounding waters, as well as to novel taxa. Of particular interest, in terms of their antimicrobial production, are bacilli, lactic acid bacteria and actinobacteria. Already, a limited number of novel bacteriocins from marine fish gut isolates have been identified and characterised. These include Formicin, a class I (lanthipeptide) bacteriocin from mackerel, several class IIa bacteriocins, and CAMT6, a very recently identified class IId bacteriocin. These novel bacteriocins cover a range of molecular structures, with varying spectra of activity – some of which were capable of targeting important pathogenic strains, such as Clostridium difficile and Listeria monocytogenes. Bacteriocins from marine fish microbiota also have diverse applications, not only for therapeutic, but also as food preservatives and probiotics. This provides great scope for the potential of finding novel bacteriocins from deep-sea fish microbiomes. Chapter two outlines an exploration of bacterial isolates from the gut and skin of deep-sea fish for antimicrobial production. In vitro screening was initially used to screen for antimicrobial producers with activity against various indicators including foodborne pathogenic bacteria. Subsequent in silico screening of the genomes of selected producers revealed the presence of a wide range of secondary metabolite biosynthetic gene clusters (BGCs) as well as potentially novel bacteriocins, including class I (lanthipeptide), class IIc (circular) and class IId bacteriocins. Genomic screening also revealed the almost complete absence of antimicrobial resistance genes. Chapter three outlines the description of a novel species, Winogradskyella bathintestinalis APC 3343, which was isolated from the intestine of a deep-sea dragon fish, Malacosteus niger, as part of the screening study. This yellow pigment-producing strain was differentiated from related type strains of Winogradskyella species based on a combination of 16S, genomic, biochemical, and phenotypic characterisation. This study represents one of first to characterise a novel Winogradskyella species isolated from a deep-sea fish. Chapter four describes the characterisation of a novel Planococcus species, isolated from the skin of a deep-sea ‘snub nose spiny eel’ (Notacanthus chemnitzii), for which the name Planococcus notacanthi was proposed. This strain, APC 4016, had been shown to inhibit the growth of Gram-positive target strains and was subsequently found encode a potentially novel lanthipeptide with similarity to cerecidin of Bacillus cereus. Based on phylogenetic analysis and its distinctive phenotypic characteristics, such as a tolerance of a wide range of growth conditions and the presence of menaquinone 5 as a respiratory quinone, Planococcus notacanthi was deemed a novel species, with APC 4016 as the type strain. We also explored the application of these deep-sea isolates and their DNA as controls for determining relative and/or absolute quantification of bacteria, in terms of cell numbers, in human metagenomic sequencing experiments. Quantified genomic DNA from two deep-sea species (crucially that have not been identified in human microbiome samples) was applied to human faecal samples and subsequently extracted and detected using 16S rDNA sequencing and qPCR, alongside the microbiome DNA. The preliminary data shows that the “spiked-in” deep-sea DNA has the potential to be used as a marker for relative abundance of bacterial cell numbers. Chapter five outlines the identification of an agarolytic (agar-degrading) isolate from the skin of a deep-sea fish and the subsequent molecular characterisation of one β-agarase and one putative B agarase encoded by the isolate. Sequence analysis of the two agarase proteins, Aga4017A and Aga4017B, showed that they shared structural similarities and key characteristics to GH16 and GH50 family β-agarases, respectively. Recombinant pCR2.1-TOPO vectors encoding aga4017A or aga4017B were created and cloned into E. coli TOP10. Transformants containing this pCR2.1-TOPO_aga4017A vector were able to express the agarase protein and exhibited agarolytic activity. The predicted 3D model of Aga4017A was also elucidated using Alphafold2 and revealed it to be a globular protein with distinctive modules corresponding to a signal peptide, a catalytic GH16 β-agarase domain and a ricin B lectin -like carbohydrate-binding domain. Overall, this work demonstrates the biodiscovery potential of the microbiome of deep-sea fish, in terms of its microbials inhabitants, the antimicrobials they produce, and also their functionalities, which may have applications for utilisation in the field of microbiome research. | en |
| dc.description.status | Not peer reviewed | en |
| dc.description.version | Accepted Version | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.citation | Uniacke-Lowe, S. M. 2024. Characterisation and applications of bacteriocinogenic Isolates from the deep-sea fish microbiome. PhD Thesis, University College Cork. | |
| dc.identifier.endpage | 224 | |
| dc.identifier.uri | https://hdl.handle.net/10468/16393 | |
| dc.language.iso | en | |
| dc.publisher | University College Cork | en |
| dc.rights | © 2024, Shona Maria Uniacke-Lowe. | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Bacteriocin | en |
| dc.subject | Deep-sea | en |
| dc.subject | Antimicrobial | en |
| dc.subject | Microbiome | en |
| dc.title | Characterisation and applications of bacteriocinogenic Isolates from the deep-sea fish microbiome | |
| dc.type | Doctoral thesis | en |
| dc.type.qualificationlevel | Doctoral | |
| dc.type.qualificationname | PhD - Doctor of Philosophy |
Files
Original bundle
1 - 3 of 3
Loading...
- Name:
- UniackeLoweSM_PhD2024.docx
- Size:
- 81.87 MB
- Format:
- Microsoft Word XML
- Description:
- Full Text E-thesis (Word)
Loading...
- Name:
- UniackeLoweSM_PhD2024.pdf
- Size:
- 8.96 MB
- Format:
- Adobe Portable Document Format
- Description:
- Full Text E-thesis
Loading...
- Name:
- UniackeLoweSM_Submission for examination form.pdf
- Size:
- 405.14 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 5.2 KB
- Format:
- Item-specific license agreed upon to submission
- Description: